HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marcin Ekiert Selected Research

1- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazene

1/2019Temporal inhibition of mouse mammary gland cancer metastasis by CORM-A1 and DETA/NO combination therapy.
11/2018Combination Therapy with DETA/NO and Clopidogrel Inhibits Metastasis in Murine Mammary Gland Cancer Models via Improved Vasoprotection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marcin Ekiert Research Topics

Disease

6Neoplasms (Cancer)
05/2022 - 09/2012
4Breast Neoplasms (Breast Cancer)
05/2022 - 09/2012
3Neoplasm Metastasis (Metastasis)
01/2019 - 01/2013
1Obesity
03/2020
1Disease Progression
09/2012

Drug/Important Bio-Agent (IBA)

2Fibrinogen (Factor I)FDA Link
01/2019 - 11/2018
21- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazeneIBA
01/2019 - 11/2018
2Proteins (Proteins, Gene)FDA Link
01/2013 - 09/2012
1Telomerase (Telomerase Reverse Transcriptase)IBA
05/2022
1Biomarkers (Surrogate Marker)IBA
05/2022
1Retinol-Binding Proteins (Retinoid Binding Proteins)IBA
03/2020
1AdipokinesIBA
03/2020
1Endothelin-1 (Endothelin 1)IBA
01/2019
1SelectinsIBA
01/2019
1sodium boranocarbonateIBA
01/2019
1Cadherins (E-Cadherin)IBA
11/2018
1Clopidogrel (Plavix)FDA Link
11/2018
1Cytostatic AgentsIBA
01/2013
1Messenger RNA (mRNA)IBA
01/2013
1XenobioticsIBA
09/2012

Therapy/Procedure

2Therapeutics
01/2019 - 11/2018